Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ovid Therapeutics (OVID) Tax Provisions (2021 - 2022)

Ovid Therapeutics (OVID) has disclosed Tax Provisions for 2 consecutive years, with -$50000.0 as the latest value for Q2 2022.

  • For the quarter ending Q2 2022, Tax Provisions fell 103.39% year-over-year to -$50000.0, compared with a TTM value of -$50000.0 through Mar 2023, down 105.72%, and an annual FY2021 reading of $1.3 million, changed N/A over the prior year.
  • Tax Provisions was -$50000.0 for Q2 2022 at Ovid Therapeutics, down from $50000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $1.5 million in Q2 2021 and bottomed at -$349714.0 in Q4 2021.